Renal is no go, defInitely mentioned here before.
That market is controlled by a duopoly which are involved in all stages of patient care. IPD's SOZO is useful only in one or two stages of that cycle. The 2 majors whilest interested in a partnership will not pay in parity of current arrangements with cancer centres thus this path was not pursued.
i don't believe BOD acted in my best interest at last CR so I voted for a change.
Renal is no go, defInitely mentioned here before. That market is...
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
-0.004(4.76%) |
Mkt cap ! $161.8M | |||
| Open | High | Low | Value | Volume |
| 8.4¢ | 8.4¢ | 7.8¢ | $377.9K | 4.762M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 221536 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.1¢ | 92693 | 2 |
View Market Depth
| Last trade - 16.10pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.9¢ |
Change
-0.004 ( 5.95 %) |
||||
| Open | High | Low | Volume | ||
| 8.1¢ | 8.2¢ | 7.8¢ | 957832 | ||
| Last updated 15.56pm 01/05/2024 ? | |||||
| IPD (ASX) Chart |